Most strokes are intrinsically ischemic, which means that they are caused by vascular obstruction leading to disruption of cerebral blood flow (CBF). CBF disruption affects the region of the lesion, homologous sites in the contralateral hemisphere, and even remote regions usually associated with the site of injury. Therefore, CBF monitoring is of great importance in stroke research and is an important tool for the preparation and validation of animal models of stroke. CBF functional mapping is widely used to monitor hemodynamic changes in the healthy brain as well as changes associated with cerebrovascular disease.
Fig. 1. Representative LSCI imaging of cerebral cortical blood flow monitoring at different time points. (Aswendt et al., 2014)
Ace Therapeutics can measure CBF in animal stroke models. Our service combines a range of cutting-edge monitoring methods to ensure accurate and reliable data collection. CBF monitoring is widely used in preclinical studies of stroke, where changes in cerebral blood flow can be reflected in pathophysiological states.
The main technologies used in our CBF monitoring service include:
To ensure the success and reliability of our CBF monitoring services, we carefully select the most appropriate methodology based on the experimental requirements, the species under study, and the modeling technique. Our team of highly skilled experts works closely with researchers to customize CBF monitoring protocols, taking into account factors such as cost-effectiveness and convenience.
Ace Therapeutics's CBF monitoring service provides researchers with a comprehensive, state-of-the-art approach to the study of stroke. Accelerate your stroke research by partnering with Ace Therapeutics. If you are interested in our services, please do not hesitate to contact us!
We are committed to accelerating progress in stroke research and drug development.